Elizabeth Cwyk of Tannersville, Pa., says she developed a pelvic infection and damage to her reproductive system after using a Dalkon Shield.

She has been unable to conceive despite reconstructive surgery and three in vitro fertilization procedures. She desperately wants a child, but her biological clock is running -- she'll be 36 on Sept. 7.

These facts could qualify Cwyk (pronounced Swick) for up to $15,000 from a $15 million emergency fund for women who are nearing 40 and whose only hope of bearing a child is reconstructive surgery, in vitro fertilization or both.

But an appeals court has frozen the fund, possibly until winter.

Cwyk says she feels "extreme anger at what was done to me," at the bankrupt A.H. Robins Co., which made the intrauterine contraceptive device, and at the committee of outside stockholders, which requested the freeze pending an appeal of a court order to establish the emergency fund.

"The agony is endless," she said in an interview. "I feel terrible sorrow and envy, mixed with joy, when a friend or relative announces she is pregnant," she said.

"I feel a sense of alienation and emptiness when people discuss their children, when I'm picking out a baby gift for someone else, knowing that my husband and I may be forever denied this miracle of a child, which is a natural right for two people in love."

Cwyk said her husband, William, a microbiologist, has been "very supportive. He says that life is still worth living and that we can have a good life together."

She denounced the shareholders committee and the company, which opposed the proposal for an emergency fund from August 1985, when it filed for Chapter 11 protection, until last May, when it allied itself with the Dalkon Shield Claimants Committee and the court-appointed examiner in urging the fund.

"I feel that I was in essence mutilated because of the failure and refusal of the manufacturer to make sure the product was safe," Cwyk said.

Robins has steadfastly maintained that the shield was a safe and effective IUD when "properly used."

Cwyk accused Robins of "unscrupulous delaying tactics {that} are ignoring, or more likely deliberately forcing, these women to wait beyond their childbearing years, so that they will give up the fight for damages and/or money to use for the only rays of hope they have left."

Last month, after several dozen shield victims marched in an anti-Robins demonstration at the U.S. courthouse in Richmond, a company spokesman said, "No party wants to bring this to a close any more than Robins does."

Cwyk said, "What the equity committee is doing is an additional heinous crime. They're being deliberately cruel to people they have already victimized."

Committee lawyer Robert M. Miller said, "We're not trying to deny anybody justice."

Cwyk used the Dalkon Shield from mid-1974, about the time Robins stopped selling it, until 1976.

Later she had persistent low-grade pelvic inflammatory disease that caused several bladder infections and other problems.

Starting in 1980, the couple tried for a year to have a baby. In late 1981, an infertility specialist found adhesions, or obstructions, in her Fallopian tubes, the pathways by which ova reach the womb.

He indicated his belief that the Dalkon Shield was the cause, she said, noting that she had always been "very healthy."

In 3 1/2 hours of surgery in 1982 most of the adhesions were cleared, and she was told her chances of conceiving naturally had much improved. Still she did not become pregnant.

Her husband's health insurance covered all but a few hundred dollars of the cost of the surgery.

In September 1983, she had an in vitro fertilization, but did not develop enough retrievable ova. The cost to the Cwyks was relatively small.

In April 1984, a second procedure successfully fertilized ova that were transferred into the uterus, but even then she did not conceive. The bills came to about $5,000.

"I did not file a lawsuit because I wanted so much for the in vitro to work," she said. "It was a form of denial. I wanted to put that out of my mind, and I pursued the only positive course I could."

Last May, she had an in vitro procedure in Ontario, where she and her husband were living, but did not conceive even though three ova were transferred into her womb. Except for a $500 fee, the provincial government paid the bill.

The costs of an in vitro procedure have risen sharply, but, Cwyk said, so have the chances of success. She wants to try a fourth time -- and wants Robins to pay the bill.

Meanwhile, she and her husband are thinking about adoption.